|
HY-100443B-1mg
|
MedChemexpress LLC
|
(-)-PX20606 (trans isomer) [CAS 1268244-88-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100443B-2mg
|
MedChemexpress LLC
|
(-)-PX20606 (trans isomer) [CAS 1268244-88-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100013A1-10mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-25mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-5mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-50mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-1mL
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-120878A-10mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-100mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-25mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-5mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-50mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-1mL
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-119486A-10mg
|
MedChemexpress LLC
|
(Rac)-Tavapadon [CAS 1643462-64-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-119486A-100mg
|
MedChemexpress LLC
|
(Rac)-Tavapadon [CAS 1643462-64-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-119486A-5mg
|
MedChemexpress LLC
|
(Rac)-Tavapadon [CAS 1643462-64-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-119486A-50mg
|
MedChemexpress LLC
|
(Rac)-Tavapadon [CAS 1643462-64-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-119486A-1mL
|
MedChemexpress LLC
|
(Rac)-Tavapadon [CAS 1643462-64-9] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-125975-1mg
|
MedChemexpress LLC
|
1-Naphthyl 3,5-dinitrobenzoate [CAS 93261-39-3]
|
|
|
|
|
HY-112362-10mg
|
MedChemexpress LLC
|
3-(4-Pyridyl)indole [CAS 7272-84-6]
|
|
COVID-19-anti-virus
|
|
|
HY-112362-5mg
|
MedChemexpress LLC
|
3-(4-Pyridyl)indole [CAS 7272-84-6]
|
|
COVID-19-anti-virus
|
|
|
HY-15595A-10mg
|
MedChemexpress LLC
|
360A (iodide) [CAS 737763-37-0]
|
|
Cancer-programmed cell death
|
|
|
HY-15595A-100mg
|
MedChemexpress LLC
|
360A (iodide) [CAS 737763-37-0]
|
|
Cancer-programmed cell death
|
|
|
HY-15595A-5mg
|
MedChemexpress LLC
|
360A (iodide) [CAS 737763-37-0]
|
|
Cancer-programmed cell death
|
|
|
HY-15595A-50mg
|
MedChemexpress LLC
|
360A (iodide) [CAS 737763-37-0]
|
|
Cancer-programmed cell death
|
|
